Jorge Matias-Guiu
Overview
Explore the profile of Jorge Matias-Guiu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
156
Citations
1744
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
21.
Delgado-Alonso C, Diez-Cirarda M, Pagan J, Perez-Izquierdo C, Oliver-Mas S, Fernandez-Romero L, et al.
Eur J Neurol
. 2023 Oct;
32(1):e16084.
PMID: 37797297
Background And Purpose: "Brain fog" is a frequent and disabling symptom that can occur after SARS-CoV-2 infection. However, its clinical characteristics and the relationships among brain fog and objective cognitive...
22.
Benito-Leon J, Del Pino A, Aladro Y, Cuevas C, Domingo-Santos A, Galan Sanchez-Seco V, et al.
Mult Scler
. 2023 Sep;
29(11-12):1393-1405.
PMID: 37772510
Background: Radiologically isolated syndrome (RIS) patients might have psychiatric and cognitive deficits, which suggests an involvement of major resting-state functional networks. Notwithstanding, very little is known about the neural networks...
23.
Hernandez-Lorenzo L, Gil-Moreno M, Ortega-Madueno I, Cardenas M, Diez-Cirarda M, Delgado-Alvarez A, et al.
CNS Neurosci Ther
. 2023 Jul;
30(2):e14382.
PMID: 37501389
Aims: The AT(N) classification system not only improved the biological characterization of Alzheimer's disease (AD) but also raised challenges for its clinical application. Unbiased, data-driven techniques such as clustering may...
24.
Diez-Cirarda M, Yus-Fuertes M, Sanchez-Sanchez R, Gonzalez-Rosa J, Gonzalez-Escamilla G, Gil-Martinez L, et al.
EBioMedicine
. 2023 Jul;
94:104711.
PMID: 37453364
Background: Cognitive deficits are among the main disabling symptoms in COVID-19 patients and post-COVID syndrome (PCS). Within brain regions, the hippocampus, a key region for cognition, has shown vulnerability to...
25.
Gomez-Pinedo U, Matias-Guiu J, Ojeda-Hernandez D, Fuente-Martin S, Mohamed-Fathy Kamal O, Benito-Martin M, et al.
Cells
. 2023 Jun;
12(11).
PMID: 37296635
The implantation of oligodendrocyte precursor cells may be a useful therapeutic strategy for targeting remyelination. However, it is yet to be established how these cells behave after implantation and whether...
26.
Delgado-Alvarez A, Nielsen T, Delgado-Alonso C, Valles-Salgado M, Lopez-Carbonero J, Garcia-Ramos R, et al.
Front Aging Neurosci
. 2023 May;
15:1134111.
PMID: 37213535
Background: The Cross-Cultural Neuropsychological Test Battery (CNTB) is a novel test battery specifically designed to reduce the impact of multiculturality in cognitive assessment. Objective: We aimed to validate the CNTB...
27.
Oliver-Mas S, Delgado-Alonso C, Delgado-Alvarez A, Diez-Cirarda M, Cuevas C, Fernandez-Romero L, et al.
Brain Commun
. 2023 Apr;
5(2):fcad117.
PMID: 37091591
Fatigue is one of the most frequent and disabling symptoms of the post-COVID syndrome. In this study, we aimed to assess the effects of transcranial direct current stimulation on fatigue...
28.
Gascon-Gimenez F, Alcala C, Ramio-Torrenta L, Montero P, Matias-Guiu J, Gomez-Estevez I, et al.
Front Neurol
. 2023 Mar;
14:1060696.
PMID: 36959824
Introduction: Rituximab (RTX) is considered a potential therapeutic option for relapsing-remitting (RRMS) and progressive forms (PMS) of multiple sclerosis (MS). The main objective of this work was to investigate the...
29.
Delgado-Alvarez A, Delgado-Alonso C, Goudsmit M, Garcia-Ramos R, Gil-Moreno M, Valles-Salgado M, et al.
Front Psychol
. 2023 Jan;
13:1043721.
PMID: 36687822
Objective: The Cross-Cultural Dementia (CCD) is a new screening tool to evaluate cognitive impairment based on a cross-cultural perspective to reduce the bias of education, and language and cultural differences....
30.
Development of criteria for cognitive dysfunction in post-COVID syndrome: the IC-CoDi-COVID approach
Matias-Guiu J, Herrera E, Gonzalez-Nosti M, Krishnan K, Delgado-Alonso C, Diez-Cirarda M, et al.
Psychiatry Res
. 2022 Dec;
319:115006.
PMID: 36521337
Background: We aimed to develop objective criteria for cognitive dysfunction associated with the post-COVID syndrome. Methods: Four hundred and four patients with post-COVID syndrome from two centers were evaluated with...